METHYL SALICYLATE, MENTHOL, UNSPECIFIED FORM, AND CAMPHOR (SYNTHETIC)

METHYL SALICYLATE, MENTHOL, UNSPECIFIED FORM, AND CAMPHOR (SYNTHETIC) was reported 80 times

METHYL SALICYLATE, MENTHOL, UNSPECIFIED FORM, AND CAMPHOR (SYNTHETIC) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHEMICAL BURN OF RESPIRATORY TRACT 1 0.0128
1 SERUM AMYLOID A PROTEIN INCREASED 1 0.0065
2 CRYOPYRIN ASSOCIATED PERIODIC SYNDROME 1 0.0051
3 EPIDURAL INJECTION 1 0.0051
4 EXPOSURE VIA INHALATION 1 0.0046
5 CATHETER SITE RELATED REACTION 1 0.0013
6 PERIORBITAL PAIN 1 0.0012
7 MEDICATION OVERUSE HEADACHE 1 0.0012
8 BURNS SECOND DEGREE 2 0.0011
9 BURNS THIRD DEGREE 1 0.0009
10 CARDIAC HYPERTROPHY 1 0.0009
11 CATHETER SITE DISCHARGE 1 0.0009
12 OVARIAN CYST RUPTURED 1 0.0008
13 TONGUE DRY 1 0.0007
14 HALLUCINATIONS, MIXED 3 0.0007
15 CONNECTIVE TISSUE DISORDER 1 0.0007
16 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
17 ACCIDENTAL DRUG INTAKE BY CHILD 1 0.0007
18 NIPPLE PAIN 1 0.0005
19 MENOPAUSE 1 0.0004
20 ANORGASMIA 1 0.0004
21 JOINT LOCK 1 0.0004
22 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
23 SINUS HEADACHE 2 0.0003
24 ATYPICAL PNEUMONIA 1 0.0003
25 PLANTAR FASCIITIS 1 0.0003
26 BOWEL MOVEMENT IRREGULARITY 2 0.0003
27 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
28 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
29 OESOPHAGEAL CANDIDIASIS 1 0.0003
30 ENURESIS 1 0.0002
31 SLEEP TERROR 1 0.0002
32 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
33 HEPATIC PAIN 1 0.0002
34 LIGAMENT RUPTURE 1 0.0002
35 HAEMOGLOBIN INCREASED 1 0.0002
36 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
37 SKIN TIGHTNESS 1 0.0002
38 VULVOVAGINAL PAIN 1 0.0002
39 INCREASED UPPER AIRWAY SECRETION 1 0.0002
40 SENSITIVITY TO WEATHER CHANGE 1 0.0002
41 PHARYNGOLARYNGEAL PAIN 1 0.0002
42 PRE-EXISTING CONDITION IMPROVED 1 0.0002
43 PROCTALGIA 1 0.0002
44 HERPES SIMPLEX 1 0.0002
45 TENDON DISORDER 1 0.0002
46 SKIN MASS 1 0.0001
47 MENINGITIS 1 0.0001
48 ONYCHOCLASIS 1 0.0001
49 APPLICATION SITE REACTION 1 0.0001
50 SEASONAL ALLERGY 2 0.0001
51 CEREBRAL DISORDER 1 0.0001
52 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
53 CONCUSSION 1 0.0001
54 MULTIPLE ALLERGIES 1 0.0001
55 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
56 FRUSTRATION TOLERANCE DECREASED 1 0.0001
57 ESCHERICHIA INFECTION 1 0.0001
58 INADEQUATE ANALGESIA 1 0.0001
59 BLOOD CALCIUM INCREASED 1 0.0001
60 INCREASED TENDENCY TO BRUISE 1 0.0001
61 OVARIAN CANCER 1 0.0001
62 FLANK PAIN 1 0.0001
63 SPUTUM DISCOLOURED 1 0.0001
64 THERAPY CHANGE 1 0.0001
65 DISORIENTATION 4 0.0001
66 OVARIAN CYST 1 0.0001
67 EUPHORIC MOOD 1 0.0001
68 PRODUCT ODOUR ABNORMAL 1 0.0001
69 BODY HEIGHT DECREASED 1 0.0001
70 IRRITABLE BOWEL SYNDROME 2 0.0001
71 DECREASED ACTIVITY 1 0.0001
72 ORAL PAIN 2 0.0001
73 APPLICATION SITE PRURITUS 2 0.0001
74 MICTURITION URGENCY 1 0.0001
75 SPLENOMEGALY 1 0.0001
76 SPINAL PAIN 1 0.0001
77 BURSITIS 1 0.0001
78 INCORRECT PRODUCT STORAGE 1 0.0001
79 PRODUCT TASTE ABNORMAL 1 0.0001
80 APPLICATION SITE RASH 1 0.0001
81 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
82 BLINDNESS UNILATERAL 1 0.0001
83 PAIN IN JAW 2 0.0001
84 MUSCULOSKELETAL CHEST PAIN 1 0.0001
85 TENDONITIS 1 0.0001
86 MUSCLE TIGHTNESS 1 0.0001
87 BLOOD POTASSIUM INCREASED 1 0.0001
88 URINARY RETENTION 2 0.0001
89 MUSCULOSKELETAL DISCOMFORT 1 0.0001
90 THIRST 1 0.0001
91 TOOTHACHE 1 0.0001
92 BLISTER 3 0.0001
93 DYSPNOEA EXERTIONAL 2 0.0001
94 CHOLESTASIS 1 0.0001
95 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
96 SINUS DISORDER 1 0.0001
97 FULL BLOOD COUNT DECREASED 1 0.0000
98 PRODUCT PHYSICAL ISSUE 1 0.0000
99 RIB FRACTURE 1 0.0000
100 PULMONARY HYPERTENSION 1 0.0000
101 FAECES DISCOLOURED 1 0.0000
102 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
103 APPLICATION SITE PAIN 1 0.0000
104 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
105 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
106 SKIN IRRITATION 2 0.0000
107 MENTAL IMPAIRMENT 1 0.0000
108 NEURALGIA 1 0.0000
109 AGEUSIA 1 0.0000
110 ANAPHYLACTIC SHOCK 1 0.0000
111 APPLICATION SITE ERYTHEMA 1 0.0000
112 FREQUENT BOWEL MOVEMENTS 1 0.0000
113 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
114 BACK PAIN 8 0.0000
115 PSYCHOTIC DISORDER 1 0.0000
116 IRRITABILITY 2 0.0000
117 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
118 DISCOMFORT 2 0.0000
119 NEUROPATHY PERIPHERAL 3 0.0000
120 CYSTITIS 1 0.0000
121 CHOLELITHIASIS 1 0.0000
122 TREMOR 5 0.0000
123 ANGER 1 0.0000
124 HAEMATURIA 1 0.0000
125 GASTRIC DISORDER 1 0.0000
126 RASH MACULAR 1 0.0000
127 BURNING SENSATION 2 0.0000
128 MOBILITY DECREASED 2 0.0000
129 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
130 CRYING 1 0.0000
131 C-REACTIVE PROTEIN INCREASED 1 0.0000
132 BRONCHITIS 2 0.0000
133 RHEUMATOID ARTHRITIS 3 0.0000
134 PERIPHERAL SWELLING 4 0.0000
135 POLLAKIURIA 1 0.0000
136 ROAD TRAFFIC ACCIDENT 1 0.0000
137 URTICARIA 4 0.0000
138 OSTEOARTHRITIS 1 0.0000
139 HYPOACUSIS 1 0.0000
140 PSORIASIS 3 0.0000
141 MUSCULOSKELETAL STIFFNESS 2 0.0000
142 RENAL FAILURE 3 0.0000
143 THERAPY NON-RESPONDER 1 0.0000
144 NEPHROLITHIASIS 1 0.0000
145 SKIN DISCOLOURATION 1 0.0000
146 COGNITIVE DISORDER 1 0.0000
147 DYSPHAGIA 2 0.0000
148 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
149 CONTUSION 2 0.0000
150 LUNG DISORDER 1 0.0000
151 CHEST DISCOMFORT 2 0.0000
152 SINUSITIS 2 0.0000
153 THERAPY CESSATION 1 0.0000
154 SPEECH DISORDER 1 0.0000
155 DRUG EFFECT DECREASED 1 0.0000
156 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
157 ARTHROPATHY 1 0.0000
158 NECK PAIN 1 0.0000
159 PANCYTOPENIA 1 0.0000
160 OXYGEN SATURATION DECREASED 1 0.0000
161 FLATULENCE 1 0.0000
162 SEIZURE 2 0.0000
163 NASAL CONGESTION 1 0.0000
164 DISEASE PROGRESSION 2 0.0000
165 STOMATITIS 1 0.0000
166 VISUAL IMPAIRMENT 2 0.0000
167 HYPERHIDROSIS 2 0.0000
168 AMNESIA 1 0.0000
169 PRODUCT DOSE OMISSION 1 0.0000
170 ERYTHEMA 3 0.0000
171 MEMORY IMPAIRMENT 2 0.0000
172 INJURY 1 0.0000
173 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
174 PAIN IN EXTREMITY 4 0.0000
175 WEIGHT INCREASED 3 0.0000
176 UNEVALUABLE EVENT 1 0.0000
177 PAIN 8 0.0000
178 ARTHRITIS 1 0.0000
179 CARDIAC FAILURE CONGESTIVE 1 0.0000
180 DRY MOUTH 1 0.0000
181 GASTROINTESTINAL DISORDER 1 0.0000
182 ASTHENIA 4 0.0000
183 MIGRAINE 1 0.0000
184 PRURITUS 4 0.0000
185 ATRIAL FIBRILLATION 1 0.0000
186 PRODUCT DOSE OMISSION ISSUE 3 0.0000
187 DYSPEPSIA 1 0.0000
188 NAUSEA 8 0.0000
189 SYNCOPE 1 0.0000
190 HYPOTENSION 2 0.0000
191 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
192 FLUSHING 1 0.0000
193 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
194 ARTHRALGIA 4 0.0000
195 FALL 3 0.0000
196 ASTHMA 1 0.0000
197 DYSPNOEA 5 0.0000
198 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
199 ABDOMINAL PAIN 2 0.0000
200 CHILLS 1 0.0000
201 VOMITING 4 0.0000
202 JOINT SWELLING 1 0.0000
203 OEDEMA PERIPHERAL 1 0.0000
204 DRUG INEFFECTIVE 10 0.0000
205 WEIGHT DECREASED 2 0.0000
206 COUGH 2 0.0000
207 HYPOAESTHESIA 1 0.0000
208 BLOOD PRESSURE INCREASED 1 0.0000
209 FATIGUE 5 0.0000
210 PNEUMONIA 2 0.0000
211 DRUG DOSE OMISSION 1 0.0000
212 DIZZINESS 3 0.0000
213 ABDOMINAL DISCOMFORT 1 0.0000
214 MYALGIA 1 0.0000
215 URINARY TRACT INFECTION 1 0.0000
216 PYREXIA 2 0.0000
217 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
218 MUSCLE SPASMS 1 0.0000
219 NASOPHARYNGITIS 1 0.0000
220 CHEST PAIN 1 0.0000
221 HYPERSENSITIVITY 1 0.0000
222 PRODUCT USE ISSUE 1 0.0000
223 GAIT DISTURBANCE 1 0.0000
224 ABDOMINAL PAIN UPPER 1 0.0000
225 HEADACHE 3 0.0000
226 DIARRHOEA 3 0.0000
227 RASH 2 0.0000
228 CONSTIPATION 1 0.0000
229 DEPRESSION 1 0.0000
230 INCORRECT DOSE ADMINISTERED 1 0.0000
231 DECREASED APPETITE 1 0.0000
232 FEELING ABNORMAL 1 0.0000
233 INSOMNIA 1 0.0000
234 ANXIETY 1 0.0000
235 CONDITION AGGRAVATED 1 0.0000
236 INJECTION SITE PAIN 1 0.0000
237 MALAISE 1 0.0000